Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Half Year Trading Update

9 Jul 2020 07:00

RNS Number : 4605S
Science in Sport PLC
09 July 2020
 

 

9 July 2020

 

 

 

SCIENCE IN SPORT PLC

("Company" or "Group")

Half Year Trading Update and Notice of Results

 

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, is pleased to announce its pre-close trading statement for the six months to 30 June 2020.

 

Contingency plans were enacted in early March to deal with the COVID-19 pandemic, including significant cost reductions, together with an equity raise in April. Changing consumer behaviour has accelerated our shift to online channels, and we have done this while improving margins.

 

Our USA business has been streamlined and has continued to grow strongly while sharply reducing cash consumption. Export Retail delivered growth in a challenging environment, and the first signs of increased activity in UK Retail channels are now apparent. Supply chain efficiencies continue to drive improved gross margin.

 

Group revenue for the period was ÂŁ23.6m, down 5% on last year (H1 2019: ÂŁ24.9m) reflecting the severe Q2 disruption caused in all markets by the COVID-19 pandemic. Science in Sport delivered revenue of ÂŁ11.9m, down 5% (H1 2019: ÂŁ12.5m) while PhD delivered ÂŁ11.7m, down 6% on 2019 (H1 2019: ÂŁ12.4m).

 

Online channels performed very strongly. Our E-Commerce platform delivered revenues of ÂŁ6.0m across all markets, 27% ahead of 2019. Amazon was 22% ahead, with revenues of ÂŁ4.1m. Online accounted for 42% of total business at the end of H1, up from 32% in 2019.

 

Export Retail delivered revenue of ÂŁ5.8m, 2% up (H1 2019: ÂŁ5.7m) in challenging conditions. UK Retail has seen the hardest downturn from the COVID-19 lockdown and ÂŁ7.7m revenue is 31% below last year (2019: ÂŁ11.2m). We are seeing some increase in demand and are cautiously optimistic.

 

USA delivered revenue of ÂŁ1.5m, 30% ahead of last year. Robust growth was delivered in Amazon and the SiS.com platform. We expect a significantly reduced EBITDA loss in the USA, given substantial progress from a leaner cost base.

 

Sales from new products were ÂŁ1.4m for the period, 8% ahead of the corresponding number in 2019. PhD Smart Plant and PhD Smart Cakes delivered ÂŁ1m of the total. A strong pipeline will drive revenue for both brands in the second half.

 

Supply chain synergies in operations and purchasing, together with margin improvement from E-Commerce resulted in gross margin of 47.7% which is 290bps ahead of last year (H1 2019: 44.8%).

 

Given improved margins and reduced costs, together with a ÂŁ4.5m gross equity raise, net cash is strong, with approximately ÂŁ9.0m at hand. We also secured a flexible ÂŁ8m debt facility with HSBC, which remains unused. Inventory was ÂŁ6.9m, compared with ÂŁ8.6m in 2019, and we expect to lower it further in H2.

 

Management focus is on delivery of the long-term strategy, which is underpinned by science-led innovation, investment in brand equity, focus on online channels and growth in global markets. A new gel machine will commission in late 2021, and we are assessing the supply chain footprint intending to improve service while reducing internal logistics costs.

 

While the outlook remains uncertain, and the Board believes it is too early to reinstate financial guidance, the strategic drivers of the business remain strong. We expect to return the business to its proven growth trajectory as and when the pandemic abates.

 

The Company will announce its interim results for the period ended 30 June 2020 on Wednesday 16 September 2020.

 

For further information:

 

Science in Sport plc

Stephen Moon, Chief Executive Officer

James Simpson, Chief Financial Officer

+44 (0) 20 7400 3700

LiberumNominated adviser and broker

Bidhi BhomaJames GreenwoodWill Hall

+44 (0) 20 3100 2000

 

Notes to Editors

 

About Science in Sport plc

 

Science in Sport plc is a leading sports nutrition business that develops, manufactures and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the gym lifestyle community. The Company has two highly regarded brands: PhD Nutrition, a premium protein brand targeting gym lifestyle and sports enthusiasts, and SiS, a leading brand among elite athletes and professional sports teams.

The two brands are sold internationally through multiple retail channels, both traditional and online, including major supermarkets and high street chains, specialist sports retailers and e-commerce sites including Amazon and the brands' websites. They enable the Company to address the full breadth of the performance nutrition market currently estimated at approximately £10 billion worldwide.

PhD is one of the UK's leading protein brands with a reputation for high quality and product innovation. The brand has grown rapidly, based on its core protein powders, since its launch in 2005. The range now comprises powders, bars, flapjacks, drinks and other products including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include endurance athlete Ross Edgley, WBA international champion Jordan Gill, Team GB Olympic sprinter Asha Philip and leading fitness influencer Obi Vincent. The PhD brand is an official partner to the Tough Mudder Challenge and Race Series.

SiS, founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration and endurance. SiS is the official sports nutrition supplier to many professional teams and organisations including Team INEOS Cycling, Team Ineos UK (America's Cup Team), British Cycling, Cycling Australia, USA Cycling and USA Triathlon. SiS supplies more than 100 professional football clubs in the UK, Europe and USA, and is an official partner Manchester United Football. SiS brand ambassadors include Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE.

Science in Sport is headquartered in London. Its shares joined the AIM market of the London Stock Exchange in August 2013 and trade under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFITDFITIII
Date   Source Headline
21st Oct 202210:47 amRNSForm 8.3 - Science in Sport PLC
21st Oct 20229:53 amBUSForm 8.3 - SCIENCE IN SPORT PLC
21st Oct 20229:32 amRNSForm 8.3 - [Science in Sport plc]
21st Oct 20229:11 amRNSForm 8 (DD) - Science in Sport plc
21st Oct 20229:10 amRNSForm 8 (DD) - Science in Sport plc
21st Oct 20228:30 amRNSRule 2.9 Announcement
20th Oct 202210:25 amRNSResult of GM
19th Oct 20229:10 amRNSForm 8.5 (EPT/RI)
18th Oct 20221:41 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Science in sport plc.
18th Oct 20228:47 amRNSForm 8.5 (EPT/RI)
17th Oct 20221:13 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Science in Sport Plc
17th Oct 20229:46 amRNSForm 8.5 (EPT/RI)
14th Oct 20223:28 pmRNSForm 8.3 - Science in Sport plc
14th Oct 202210:56 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Science in sport plc
14th Oct 20228:27 amRNSForm 8.5 (EPT/RI)
13th Oct 202211:46 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Science in Sport Plc
13th Oct 20228:26 amRNSForm 8.5 (EPT/RI)
12th Oct 202212:13 pmRNSForm 8.3 - Science in Sport PLC
11th Oct 20223:26 pmRNSForm 8.5 - Amendment (EPT/RI)
11th Oct 20223:17 pmRNSForm 8.3 - Science in Sport PLC
11th Oct 20222:21 pmRNSForm 8.3 - Science in Sport PLC
7th Oct 202210:02 amRNSForm 8.5 (EPT/RI)
6th Oct 20228:49 amRNSForm 8.5 (EPT/RI) - Science in Sport PLC
5th Oct 20222:52 pmRNSForm 8.3 - Science in Sport PLC
5th Oct 20222:17 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Science in Sport Plc
5th Oct 202210:07 amBUSForm 8.3 - SCIENCE IN SPORT PLC
5th Oct 20228:52 amRNSForm 8.5 (EPT/RI)
4th Oct 202211:04 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Science in Sport plc
4th Oct 20228:30 amRNSForm 8.5 (EPT/RI) - Science in Sport PLC
4th Oct 20227:00 amRNSPosting of Circular and Notice of General Meeting
3rd Oct 20225:34 pmBUSForm 8.3 - SCIENCE IN SPORT PLC - Amendment
3rd Oct 20225:08 pmRNSForm 8.3 - Science in Sport plc
3rd Oct 20224:18 pmRNSForm 8.3 - Science in Sport PLC
3rd Oct 20223:02 pmRNSForm 8.3 - Science in Sport PLC
3rd Oct 20222:43 pmRNSForm 8.3 - SCIENCE IN SPORT PLC
3rd Oct 20222:34 pmRNSForm 8 (DD) - Science in Sport PLC
3rd Oct 20221:16 pmRNSForm 8.3 - Science in Sport Plc - Amendment
3rd Oct 202212:44 pmRNSForm 8.3 - Science in Sport plc
3rd Oct 202212:14 pmRNSForm 8.3 - Science in Sport Plc
3rd Oct 202211:25 amRNSHolding(s) in Company
3rd Oct 202211:14 amGNWForm 8.3 - [Science in Sport plc - 30 09 2022 - Opening Disclosure] - (HHL)
3rd Oct 202210:04 amBUSForm 8.3 - SCIENCE IN SPORT PLC
3rd Oct 20228:39 amRNSForm 8.5 (EPT/RI)
30th Sep 20224:42 pmRNSSecond Price Monitoring Extn
30th Sep 20224:36 pmRNSPrice Monitoring Extension
30th Sep 20224:11 pmRNSResult of Placing and Director Dealings
30th Sep 202212:47 pmRNSForm 8.3 - Science in Sport PLC
30th Sep 202210:43 amBUSForm 8.3 - Science in Sport PLC
30th Sep 20229:55 amRNSForm 8.3 - [Science in Sport plc]
30th Sep 20227:01 amRNSProposed Placing and Strategic Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.